Nadine Lemaître

Also affiliated with Institut Pasteur de Lille, Centre Hospitalier Universitaire de Lille, Center for Infection and Immunity of Lille, Agents infectieux, résistance et chimiothérapie, Université de Picardie Jules Verne

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Preclinical safety and efficacy characterization of an LpxC inhibitor against Gram-negative pathogens”.

Preclinical safety and efficacy characterization of an LpxC inhibitor against Gram-negative pathogens

Science Translational Medicine(2023)10.1126/scitranslmed.adf5668

N/A

0DataRank · unranked

41 citations

C. Skyler Cochrane, Javaria Najeeb, David M. Gooden, Carly A. Sciandra, Ping Fan +13 more

Assessing the threat of Yersinia pestis harboring a multi-resistant IncC plasmid and the efficacy of an antibiotic targeting LpxC

Antimicrobial Agents and Chemotherapy(2025)10.1128/aac.01497-24

N/A

0DataRank · unranked

3 citations

Amélie Dewitte, Faniry Rakotomanimana, David M. Gooden, Eric J. Toone, Minoarisoa Rajerison +3 more